810120 | 18:0 PEG2000 PE CF
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N'-carboxyfluorescein] (ammonium salt)
18:0 PEG2000 PE CF
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[poly(ethylene glycol)2000-N'-carboxyfluorescein] (ammonium salt)
Representative Structure
The molecular weight and exact mass are averages based on the polydispersity of PEG.
C153H279N4O60P (average FW due to polydispersity of PEG)
CAS Registry Number is a Registered Trademark of the American Chemical Society
Chen H, Lin J, Shan Y, Zhengmao L. The promotion of nanoparticle delivery to two populations of gastric cancer stem cells by CD133 and CD44 antibodies. Biomed Pharmacother. 2019 Apr 29;115:108857. doi: 10.1016/j.biopha.2019.108857. [Epub ahead of print]
PubMed ID: 31048191Rasmus Eliasen, Thomas L. Andresen, Jannik B. Larsen. PEG‐Lipid Post Insertion into Drug Delivery Liposomes Quantified at the Single Liposome Level. Advanced Materials Interfaces. 2019 April 03. doi: 10.1002/admi.201801807
Kakimoto Y, Tachihara Y, Okamoto Y, Miyazawa K, Fukuma T, Tero R. Morphology and Physical Properties of Hydrophilic-Polymer-Modified Lipids in Supported Lipid Bilayers. Langmuir. 2018 May 23. doi: 10.1021/acs.langmuir.8b00870. [Epub ahead of print]
PubMed ID: 29788718
- Certificate of Analysis (Lot No. 810120C-1MG-A-011 and 5317CGA011)
- Certificate of Analysis (Lot No. 810120C-500UG-A-011 and 5317CFA011)
- Certificate of Analysis (Lot No. 810120P-1MG-A-011 and 5317PGA011)
- Certificate of Analysis (Lot No. 810120P-500UG-A-011 and 5317PFA011)
- Certificate of Analysis (Lot No. 810120C500UG-B-011 and 5317CFB011)
- Certificate of Analysis (Lot No. 810120P-1MG-B-011 and 5317PGB011)
- Certificate of Analysis (Lot No. 810120P-500UG-B-011 and 5317PFB011)
- Certificate of Analysis (Lot No. 810120C-500UG-C-011 and 5317CFC011)